Australian biotechnology manufacturers are invited to contribute to global benchmarking, with the 19th Annual Biopharmaceutical Manufacturing global survey underway.
The work is benchmarking advances in global and regional bioprocessing, new technologies, and emerging trends, including new questions that reflect current industry trends.
BioPlan Associates collects more than 280 responses from biopharma manufacturers, contract manufacturing organisations (CMOs), and service providers across 28 countries. The white paper developed from the survey will highlight the top trends in biopharma manufacturing, ensuring that the report continues to reflect critical changes and trends across the global sector.
This survey includes questions on: new product needs, facility budget changes, current capacity, future capacity constraints, expansions, use of disposables, trends and budgets in disposables, trends in downstream purification, quality management, hiring issues, and employment. The quantitative trend analysis provides details and comparisons of production by biotherapeutic developers and CMOs. It also evaluates trends over time, and assesses differences across the globe.
For each completed survey, BioPlan Associates will either send a USD $25 Amazon e-gift card or donate up to $3,000 to global health charities.
AusBiotech encourages the industry to contribute their voice to the global biomanufacturing industry’s benchmarking. Each survey takes between 15-25 minutes and responses are aggregated and confidential. Participants will receive a free copy of the white paper.
The survey is open until 15 February; complete it now.